Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Steve O'Keeffe

Advertisement

Steve O'Keeffe is the founder of Angry@Arthritis

Articles by Steve O'Keeffe

Old man suffering from knee pain. Image Credit: Adobe Stock Images/sebra

Osteoarthritis: Is a Cure on the Launch Pad?

BySteve O'Keeffe
July 26th 2023

Common advice for OA sufferers is joint replacement, but other options are on the horizon.

Advertisement

Latest Updated Articles

  • Old man suffering from knee pain. Image Credit: Adobe Stock Images/sebra
    Osteoarthritis: Is a Cure on the Launch Pad?

    July 26th 2023



Advertisement
Advertisement

Trending on PharmExec

1

CSL Names Deborah Waterhouse as CEO and Manager Director

2

The Therapeutic Areas or Deals That Might Be Negatively Impacted by MFN Deals

3

FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B

4

METiS Enters Collaboration with Eli Lilly for Next-Generation Tissue-Specific LNP Delivery Technologies

5

Hansoh Pharma Enters $15 Billion Collaboration and License Agreement with Roche

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us